Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke

被引：0
|
作者：
Zeng, Yuanyuan [1 ,4 ]
Nie, Kelin [1 ,4 ]
Wallace, Kevin L. [2 ,4 ]
Li, Fangfang [1 ,4 ]
Zhang, Jing [1 ,4 ]
Li, Caizhen [1 ,4 ]
Wang, Yingying [1 ,4 ]
Zhang, Jiewen [3 ,4 ]
Wang, Jian [1 ,4 ]
Jiang, Chao [1 ,4 ]
机构：
[1] Department of Neurology, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou,450052, China
[2] College of Mathematical and Natural Sciences, University of Maryland, College Park,MD,20742, United States
[3] Department of Neurology, People's Hospital of Zhengzhou University, Zhengzhou,450000, China
[4] Department of Anatomy, School of Basic Medical Sciences, Zhengzhou University, Henan, Zhengzhou,450001, China
来源：
Oxidative Medicine and Cellular Longevity | 2023年 / 2023卷
关键词：
D O I：
10.1155/2023/7733857
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation
    Wachtell K.
    Devereux R.B.
    Lyle P.A.
    [J]. Current Cardiology Reports, 2006, 8 (5) : 356 - 364
  • [2] Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?
    Brooks, John M.
    Chapman, Cole G.
    Suneja, Manish
    Schroeder, Mary C.
    Fravel, Michelle A.
    Schneider, Kathleen M.
    Wilwert, June
    Li, Yi-Jhen
    Chrischilles, Elizabeth A.
    Brenton, Douglas W.
    Brenton, Marian
    Robinson, Jennifer
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (11):
  • [3] Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or beta-blockers for treating hypertension
    Bisognano, John D.
    McLaughlin, Trent
    Roberts, Craig S.
    Tang, Simon S. K.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (05) : 579 - 585
  • [4] Premorbid angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in patients with sepsis
    Hasegawa, Daisuke
    Lee, Young Im
    Prasitlumkum, Narut
    Chopra, Lakshay
    Nishida, Kazuki
    Smith, Robert L.
    Sato, Ryota
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 62 : 69 - 77
  • [5] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis
    Lonn E.
    [J]. Current Atherosclerosis Reports, 2002, 4 (5) : 363 - 372
  • [6] Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With a Reduced Risk of Poststroke Epilepsy in Patients With Ischemic Stroke
    Chang, Kuo-Cheng
    Lin, Ching-Heng
    Huang, Jin-An
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (17):
  • [7] Use of spironolactone in heart failure patients receiving angiotensin-converting enzyme inhibitors and beta-blockers
    Ahmed, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) : 1851 - 1852
  • [8] Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis
    Raimondi, Sara
    Botteri, Edoardo
    Munzone, Elisabetta
    Cipolla, Carlo
    Rotmensz, Nicole
    DeCensi, Andrea
    Gandini, Sara
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (01) : 212 - 219
  • [9] Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in clinical practice
    Barrios, Vivencio
    Coca, Antonio
    Escobar, Carlos
    Enrique, Rosa
    Miguel Rincon, Luis
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (02) : 159 - 166
  • [10] Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    Raebel, Marsha A.
    [J]. CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e156 - e166
12345